Peter M Hoogerbrugge (Peter Hoogerbrugge)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Oxide Nanoparticles

Replacement Therapy

Histone Deacetylase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Rob Pieters, Hester de Groot-Kruseman, Marta Fiocco, Femke Verwer, Merian Van Overveld, Edwin Sonneveld, Vincent H J van der Velden, H Berna Beverloo, Marc Bierings, Natasja Dors, Valerie de Haas, Peter M Hoogerbrugge, Inge M Van der Sluis, Wim Tissing, Margreet A Veening, Judith M Boer, Monique Den Boer
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Renske J E van den Bijgaart, Michiel Kroesen, Ingrid C Brok, Daphne Reijnen, Melissa Wassink, Louis Boon, Peter M Hoogerbrugge, Gosse J Adema
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model. Oncoimmunology 9 (1) (2020)